Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy – Investor’s Business Daily
Why Hemophilia Patients Could Pay $1.5 Million For Gene TherapyInvestor’s Business DailyLeerink analyst Joseph Schwartz boosted his projections for hemophilia gene therapies to $1.5 million from earlier assumptions for $350,000-$500,000 per patient. So… Continue reading
